Metabolic Dyslipidemia and Risk of Coronary Heart Disease in 28,318 Adults With Diabetes Mellitus and Low-Density Lipoprotein Cholesterol <100 mg/dl

作者: Jamal S. Rana , Jennifer Y. Liu , Howard H. Moffet , Matthew D. Solomon , Alan S. Go

DOI: 10.1016/J.AMJCARD.2015.08.039

关键词: LipoproteinInternal medicineFramingham Risk ScoreCardiologyTriglycerideEndocrinologyDyslipidemiaHypertriglyceridemiaHazard ratioMedicineDiabetes mellitusCholesterol

摘要: The risk of future coronary heart disease (CHD) in subjects with diabetes and "metabolic dyslipidemia" (high triglyceride [TGs] low high-density cholesterol levels) remains a matter concern. Little is known regarding the CHD for this phenotype low-density lipoprotein (LDL-C) levels <100 mg/dl. We analyzed cohort 28,318 members (aged 30 to 90 years) Kaiser Permanente Northern California during 2002 2011 (192,356 person-years [p-y] follow-up), LDL-C mg/dl without CHD. compared incidence hazard ratios (HRs) events groups using Cox models: normal (HDL) TG (reference; n = 7,278, 25.7%); HDL high (≥ 150 mg/dl; 4,484,15.8%); (≤ 50 women ≤ 40 men) (n 4,048, 14.3%); (metabolic dyslipidemia; 12,508, 44%). Patients metabolic dyslipidemia had highest age-adjusted events/1,000 p-y (12.7/1,000 19.0/1,000 men, respectively). After multivariate adjustment age, gender, ethnicity, hypertension, smoking, statin use, duration diabetes, hemoglobin A1c, we observed an increased (HR 1.35, 95% confidence interval 1.14 1.60) men 1.62, 1.43 1.83) those TG. Even mg/dl, presence adults associated In conclusion, effective prevention strategies are needed dyslipidemia.

参考文章(14)
Robert P. Giugliano, Marc S. Sabatine, Are PCSK9 Inhibitors the Next Breakthrough in the Cardiovascular Field? Journal of the American College of Cardiology. ,vol. 65, pp. 2638- 2651 ,(2015) , 10.1016/J.JACC.2015.05.001
Haider J. Warraich, Nathan D. Wong, Jamal S. Rana, Role for Combination Therapy in Diabetic Dyslipidemia Current Cardiology Reports. ,vol. 17, pp. 32- ,(2015) , 10.1007/S11886-015-0589-5
Nadeem Sarwar, John Danesh, Gudny Eiriksdottir, Gunnar Sigurdsson, Nick Wareham, Sheila Bingham, S. Matthijs Boekholdt, Kay-Tee Khaw, Vilmundur Gudnason, Triglycerides and the Risk of Coronary Heart Disease 10 158 Incident Cases Among 262 525 Participants in 29 Western Prospective Studies Circulation. ,vol. 115, pp. 450- 458 ,(2007) , 10.1161/CIRCULATIONAHA.106.637793
Robert W. Yeh, Stephen Sidney, Malini Chandra, Michael Sorel, Joseph V. Selby, Alan S. Go, Population Trends in the Incidence and Outcomes of Acute Myocardial Infarction The New England Journal of Medicine. ,vol. 362, pp. 2155- 2165 ,(2010) , 10.1056/NEJMOA0908610
Jamal S. Rana, Maartje E. Visser, Benoit J. Arsenault, Jean-Pierre Després, Erik S.G. Stroes, John J.P. Kastelein, Nicholas J. Wareham, S. Matthijs Boekholdt, Kay-Tee Khaw, Metabolic dyslipidemia and risk of future coronary heart disease in apparently healthy men and women: The EPIC-Norfolk prospective population study International Journal of Cardiology. ,vol. 143, pp. 399- 404 ,(2010) , 10.1016/J.IJCARD.2009.03.123
Sarah Parish, Alison Offer, Robert Clarke, Jemma C. Hopewell, Michael R. Hill, James D. Otvos, Jane Armitage, Rory Collins, Lipids and Lipoproteins and Risk of Different Vascular Events in the MRC/BHF Heart Protection Study Circulation. ,vol. 125, pp. 2469- 2478 ,(2012) , 10.1161/CIRCULATIONAHA.111.073684
William B. Kannel, Lipids, diabetes, and coronary heart disease: Insights from the Framingham Study American Heart Journal. ,vol. 110, pp. 1100- 1107 ,(1985) , 10.1016/0002-8703(85)90224-8
A. J. Karter, D. Schillinger, A. S. Adams, H. H. Moffet, J. Liu, N. E. Adler, A. M. Kanaya, Elevated Rates of Diabetes in Pacific Islanders and Asian Subgroups: The Diabetes Study of Northern California (DISTANCE) Diabetes Care. ,vol. 36, pp. 574- 579 ,(2013) , 10.2337/DC12-0722